Metformin (MET) lowers hyperglycemia by reducing hepatic gluconeogenesis in the presence of insulin and improving insulin sensitivity by increasing peripheral glucose uptake and utilization [20,21,36]. The gene discussed is INS; the disease is Hyperglycemia.